The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction

Artur Dziewierz1,2, Barbara Zdzierak1,2, Wojciech Wańha3

  • 12nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, 30-688 Krakow, Poland.

Insights

Time is Muscle in ST-elevation myocardial infarction (STEMI) care. Reducing delays in treatment is crucial, as every minute of ischemia increases heart damage, mortality, and heart failure risk.

Area of Science:

  • Cardiology
  • Emergency Medicine

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a medical emergency caused by blocked coronary arteries.
  • Myocardial necrosis progresses with ischemic duration, directly impacting infarct size and patient outcomes.

Purpose of the Study:

  • To analyze components of total ischemic time in STEMI.
  • To quantify clinical consequences of treatment delays.
  • To evaluate evidence-based strategies for mitigating delays.

Main Methods:

  • Review of literature on STEMI treatment timelines.
  • Analysis of patient- and system-related delays.
  • Evaluation of interventions from fibrinolysis to primary percutaneous coronary intervention (PCI).

Main Results:

  • Total ischemic time significantly influences STEMI outcomes.
  • System-level interventions have reduced treatment times.
  • Disparities in care persist based on various demographic and geographic factors.

Conclusions:

  • Reducing ischemic time is paramount in STEMI management.
  • Targeted interventions and emerging technologies like AI can further improve outcomes.
  • Addressing persistent disparities is essential for equitable STEMI care.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
700
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
324
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K